Related Experiment Video
Updated: Feb 28, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Cardiovascular Autonomic Neuropathy Is an Independent Risk Factor for Left Ventricular Diastolic Dysfunction in
Jiewen Jin1, Weimin Wang1, Liangying Zhu1
1Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu, China.
Insights
Cardiovascular autonomic neuropathy (CAN) is an independent risk factor for left ventricular diastolic dysfunction (LVDD) in type 2 diabetes patients. Early detection and treatment of CAN are crucial for preventing LVDD.
Area of Science:
- Cardiology
- Diabetology
- Autonomic Nervous System Research
Background:
- Cardiovascular autonomic neuropathy (CAN) is a common complication in type 2 diabetes.
- Left ventricular diastolic dysfunction (LVDD) is associated with increased cardiovascular risk in diabetic patients.
- The relationship between CAN and LVDD in type 2 diabetes requires further elucidation.
Purpose of the Study:
- To investigate the association between cardiovascular autonomic neuropathy (CAN) and left ventricular diastolic dysfunction (LVDD) in patients with type 2 diabetes.
- To determine if CAN is an independent risk factor for LVDD in this population.
Main Methods:
- 315 type 2 diabetes patients were assessed for CAN using cardiovascular autonomic reflex tests, categorizing them into no CAN (NCAN), possible CAN (PCAN), and definite CAN (DCAN).
- Left ventricular diastolic function was evaluated using tissue Doppler imaging echocardiography.
- Multivariate regression analysis was employed to identify independent risk factors for LVDD.
Main Results:
- The prevalence of LVDD increased significantly with the severity of CAN (39.4% in NCAN, 45.3% in PCAN, 68.0% in DCAN; P = 0.001).
- Patients with definite CAN exhibited higher E/e' ratios (indicating elevated filling pressures) and impaired e' (diastolic performance) compared to those without CAN.
- CAN was identified as an independent risk factor for LVDD (OR = 1.628, P = 0.009).
Conclusions:
- Cardiovascular autonomic neuropathy is a significant independent risk marker for left ventricular diastolic dysfunction in type 2 diabetes.
- Prompt diagnosis and management of CAN are recommended to prevent the development of LVDD and mitigate cardiovascular risk in diabetic patients.
Aim:
This study aimed to evaluate the association between cardiovascular autonomic neuropathy (CAN) and left ventricular diastolic dysfunction (LVDD) in type 2 diabetes patients.
Methods:
315 type 2 diabetes patients from inpatients of Drum Tower Hospital were included and classified into no CAN (NCAN), possible CAN (PCAN), and definite CAN (DCAN) based on cardiovascular autonomic reflex tests. The left ventricular diastolic function was assessed by tissue Doppler imaging echocardiography.
Results:
The distribution of NCAN, PCAN, and DCAN was 11.4%, 51.1%, and 37.5%, respectively. The proportion of LVDD increased among the groups of NCAN, PCAN, and DCAN (39.4%, 45.3%, and 68.0%, P = 0.001). Patients with DCAN had higher filling pressure (E/e' ratio) (10.9 ± 2.7 versus 9.4 ± 2.8, P = 0.013) and impaired diastolic performance (e') (6.8 ± 1.7 versus 8.6 ± 2.4, P = 0.004) compared with NCAN. CAN was found to be an independent risk factor for LVDD from the multivariate regression analysis (OR = 1.628, P = 0.009, 95% CI 1.131-2.344).
Conclusions:
Our results indicated that CAN was an independent risk marker for the presence of LVDD in patients with diabetes. Early diagnosis and treatment of CAN are advocated for preventing LVDD in type 2 diabetes.
More Related Videos
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Related Concept Videos
Coronary Artery Disease I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Diabetes Mellitus: Type 2 and Gestational
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Cardiomyopathy I: Introduction and Classification